{
  "id": 757,
  "text": "732.Park et $a l .^ { 7 3 3 }$ mentionned that postoperative adjuvant CCRT (cisplatin $( 1 0 0 ~ \\mathrm { \\ m g / m ^ { 2 } } )$ , or paraplatin $( 3 5 0 ~ \\mathrm { \\ m g / m ^ { 2 } } )$ , 5-FU $[ 1 , 0 0 0 ~ \\mathrm { m g / m } ^ { 2 } ]$ , radiation therapy (45 Gy)) appears to be superior to postoperative radiotherapy or postoperative adjuvant chemotherapy alone in terms of survival rates in patients with histopathologic high-risk factors.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 732.Park et $a l .^ { 7 3 3 }$ mentionned that postoperative adjuvant CCRT (cisplatin $( 1 0 0 ~ \\mathrm { \\ m g / m ^ { 2 } } )$ , or paraplatin $( 3 5 0 ~ \\mathrm { \\ m g / m ^ { 2 } } )$ , 5-FU $[ 1 , 0 0 0 ~ \\mathrm { m g / m } ^ { 2 } ]$ , radiation therapy (45 Gy)) appears to be superior to postoperative radiotherapy or postoperative adjuvant chemotherapy alone in terms of survival rates in \n\n<question>: ",
  "ChatGPT_response_0": "根据文献提到的内容，手术后辅助放化疗（使用顺铂100mg/m2或卡铂350mg/m2，5-氟尤米汀1000mg/m2，放射疗法45 Gy）相比于单独进行放疗或单独进行术后辅助化疗，在生存率方面具有更好的表现，尤其对于具有组织病理学高风险因素的患者而言。因此，综合来看，手术后辅助放化疗可能是更为优越的选择。同时，在治疗方案的选择上，应该根据具体情况和医生建议进行个体化的决策。",
  "query": "在手术后，辅助化疗和放疗（顺铂100mg/m2，或卡铂350mg/m2，5-氟尤米汀1000mg/m2，放射疗法45 Gy）相比于单独进行放疗或单独进行术后辅助化疗，哪种方式在生存率方面更胜一筹？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在手术后，辅助化疗和放疗（顺铂100mg/m2，或卡铂350mg/m2，5-氟尤米汀1000mg/m2，放射疗法45 Gy）相比于单独进行放疗或单独进行术后辅助化疗，哪种方式在生存率方面更胜一筹？\n\n<reference text>: 732.Park et $a l .^ { 7 3 3 }$ mentionned that postoperative adjuvant CCRT (cisplatin $( 1 0 0 ~ \\mathrm { \\ m g / m ^ { 2 } } )$ , or paraplatin $( 3 5 0 ~ \\mathrm { \\ m g / m ^ { 2 } } )$ , 5-FU $[ 1 , 0 0 0 ~ \\mathrm { m g / m } ^ { 2 } ]$ , radiation therapy (45 Gy)) appears to be superior to postoperative radiotherapy or postoperative adjuvant chemotherapy alone in terms of survival rates in patients with histopathologic high-risk factors.\n\n<reply>: ",
  "response": "根据文献提到的内容，手术后辅助放化疗（使用顺铂100mg/m2或卡铂350mg/m2，5-氟尤米汀1000mg/m2，放射疗法45 Gy）相比于单独进行放疗或单独进行术后辅助化疗，在生存率方面具有更好的表现，尤其对于具有组织病理学高风险因素的患者而言。因此，综合来看，手术后辅助放化疗可能是更为优越的选择。同时，在治疗方案的选择上，应该根据具体情况和医生建议进行个体化的决策。"
}